Embargo Policy

All research presented at the ACG Annual Scientific Meeting is strictly embargoed until 8:00 a.m. on the first day of the Annual Meeting. For 2014, this is Monday, October 20 at 8:00 a.m. EDT.


 Poster 808: Olmesartan-Induced Spruelike Enteropathy in the Community Setting

Poster Presentation: Monday, Oct 20, 10:30 AM – 4:00 PM

Madeline Russell, MD
Madeline Russell, MD

Author Insight from Madeline Russell, MD, Mercer University School of Medicine

What’s new here and important for clinicians?
The importance of this case series is to point out the association of sprue-like enteropathy in patients on olmesartan. This medication is one of the more commonly prescribed medications for blood pressure control, thus, patients and clinicians alike need to be aware of this not so uncommon phenomena.

What do patients need to know?
Patients need to report and symptoms such as bloating and loose stool to their physicians so that they can consider a brief discontinuation of their medication to see if symptoms resolve rather than beginning a very expensive work up to rule out medication induce cause.

Author Contact:

Madeline Russell, MD PGY 3 Internal Medicine

Read the Abstract

Related Abstracts
P212 Olmesartan-Associated Spruelike Enteropathy
P1427 A Case of Severe Sprue-like Enteropathy Associated With Olmesartan
P1433 Olmesartan-Associated Sprue-Like Enteropathy
P1434 Not All Diarrhea and Villous Atrophy Is Celiac Disease: A Case Report on Olmesartan-Induced Enteropathy


Media Interview Requests:

Press room and video recording facilities will be available onsite. To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000. From Sunday, October 19 – Wednesday, October 22, in ACG Press Room (Room 119A; Phone 215- 418-2358) at the Pennsylvania Convention Center in Philadelphia.